Monday, December 23, 2024
HomeTagsCanSinoBIO

CanSinoBIO

CanSinoBIO’s COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

CanSino Biologics Inc. announced that the National Medical Products Administration of China ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics